PACSIN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.358000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.892800E-01
Normal-vs-Stage2
9.231200E-01
Normal-vs-Stage3
5.448200E-01
Normal-vs-Stage4
9.935000E-01
Stage1-vs-Stage2
9.689600E-01
Stage1-vs-Stage3
5.542200E-01
Stage1-vs-Stage4
8.853600E-01
Stage2-vs-Stage3
4.690800E-01
Stage2-vs-Stage4
9.044600E-01
Stage3-vs-Stage4
5.417400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.841200E-01
Normal-vs-AfricanAmerican
5.159000E-01
Normal-vs-Asian
7.754600E-01
Caucasian-vs-AfricanAmerican
6.457900E-02
Caucasian-vs-Asian
8.456600E-01
AfricanAmerican-vs-Asian
2.311800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.108400E-01
Normal-vs-Female
6.879200E-01
Male-vs-Female
4.227000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.650370E-01
Normal-vs-Age(41-60Yrs)
9.310600E-01
Normal-vs-Age(61-80Yrs)
7.803800E-01
Normal-vs-Age(81-100Yrs)
2.329600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.965430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.380600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.142000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.991250E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.231900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.690400E-01
Normal-vs-Daily Drinker
2.404600E-01
Normal-vs-Weekly Drinker
6.605000E-01
Normal-vs-Occasional Drinker
8.925200E-01
Normal-vs-Social Drinker
5.026200E-01
Non Drinker-vs-Daily Drinker
3.661700E-02
Non Drinker-vs-Weekly Drinker
5.486600E-01
Non Drinker-vs-Occasional Drinker
8.427600E-01
Non Drinker-vs-Social Drinker
4.988000E-01
Daily Drinker-vs-Weekly Drinker
3.622600E-01
Daily Drinker-vs-Occasional Drinker
7.494300E-02
Daily Drinker-vs-Social Drinker
2.289800E-01
Weekly Drinker-vs-Occasional Drinker
5.530600E-01
Weekly Drinker-vs-Social Drinker
9.605800E-01
Occasional Drinker-vs-Social Drinker
4.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.520000E-01
Normal-vs-Grade 2
9.853700E-02
Normal-vs-Grade 3
9.292000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.354000E-01
Grade 1-vs-Grade 3
2.269400E-01
Grade 1-vs-Grade 4
2.520000E-01
Grade 2-vs-Grade 3
8.295400E-01
Grade 2-vs-Grade 4
9.853700E-02
Grade 3-vs-Grade 4
9.292000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.633000E-01
Normal-vs-NonDiabetic
7.358000E-01
Diabetic-vs-NonDiabetic
8.742200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.182200E-01
Normal-vs-NoPancreatitis
7.850000E-01
Pancreatitis-vs-NoPancreatitis
4.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.059400E-01
Normal-vs-N1
9.609400E-01
N0-vs-N1
1.477410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.785000E-01
Normal-vs-TP53-NonMutant
9.697400E-01
TP53-Mutant-vs-TP53-NonMutant
3.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
